Objective: To investigate the relationship between brain natriuretic peptide and recurrence
of atrial fibrillation after successful electrical cardioversion. Methods: Medline and Embase …

A meta-analysis was undertaken to examine the relationship between plasma brain
natriuretic peptide (BNP) levels and recurrence of atrial fibrillation (AF) after successful …

Background Atrial fibrillation (AF) recurrence is common after successful direct current
cardioversion (DCCV), with a 40% rate of recurrence within the first month. Several studies …

BACKGROUND: Some small studies have suggested that low levels of brain natriuretic
peptide (BNP) measured before electrical cardioversion for atrial fibrillation (AF) may be …

Objectives The aim of this study was to assess the predictive value of plasma brain
natriuretic peptide (BNP) level for the recurrence of atrial fibrillation (AF) after successful …

BACKGROUND: Brain natriuretic peptide (BNP) is released from the heart by
hemodynamically induced muscle stretch. Patients with atrial fibrillation have higher levels …

Aim Early recurrence of atrial fibrillation (AF) is common after electrical cardioversion (ECV).
Accurate prediction of AF recurrence might allow more selective use of ECV and the …

Electrical cardioversion (ECV) can be effective in restoring sinus rhythm (SR) in the majority
of patients with atrial fibrillation (AF). Several factors that predispose to AF recurrences, such …

Natriuretic peptides might be useful to guide therapy in patients with atrial fibrillation (AF). B-
type natriuretic peptide (BNP) is elevated in patients with AF with and without heart failure [1 …

Background According to previous reports, plasma atrial natriuretic peptide levels increase
in atrial fibrillation (AF) and decrease after successful direct current (DC) cardioversion, but …